PARK7 Mouse

Parkinson Disease Protein 7 Mouse Recombinant
Cat. No.
BT2800
Source
Escherichia Coli.
Synonyms
Protein deglycase DJ-1, Parkinson disease protein 7 homolog.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

PARK7 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 212 amino acids (1-189 a.a) and having a molecular mass of 22.4kDa.
PARK7 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
PARK7 is a protein found throughout the body that plays a role in many cell functions. These include the production of sperm and fertilization, cancer development, interaction with RNA, signaling of the androgen receptor, and managing oxidative stress. Changes in the PARK7 gene can lead to a type of Parkinson's disease that starts early in life, known as autosomal recessive early-onset Parkinson's disease 7 (Park7).
Description
Recombinant PARK7 Mouse protein is produced in E. coli bacteria. It is a single chain of 212 amino acids (specifically amino acids 1-189), with a molecular weight of 22.4 kDa. The protein is not glycosylated, meaning it does not have sugars attached to it. A 23 amino acid His-tag is attached to the beginning (N-terminus) of the PARK7 protein to aid in purification, which is carried out using specialized chromatographic techniques.
Physical Appearance
The product is a clear and colorless solution that has been sterilized by filtration.
Formulation
The PARK7 protein is supplied in a solution with a concentration of 0.5 mg/ml. The solution also contains Phosphate Buffered Saline (PBS) at a pH of 7.4, 20% glycerol to protect the protein during freezing, and 1mM DTT to prevent the formation of unwanted bonds within the protein.
Stability
For short-term storage (2-4 weeks), the product can be kept at refrigerated at 4°C. For longer storage, it is recommended to freeze the product at -20°C. To further enhance long-term stability, consider adding a carrier protein such as HSA or BSA at a concentration of 0.1%. Repeated freezing and thawing of the product should be avoided.
Purity
Analysis by SDS-PAGE indicates that the purity of the PARK7 protein is greater than 90%.
Synonyms
Protein deglycase DJ-1, Parkinson disease protein 7 homolog.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMASKRAL VILAKGAEEM ETVIPVDVMR RAGIKVTVAG LAGKDPVQCS RDVMICPDTS LEDAKTQGPY DVVVLPGGNL GAQNLSESPM VKEILKEQES RKGLIAAICA GPTALLAHEV GFGCKVTTHP LAKDKMMNGS HYSYSESRVE KDGLILTSRG PGTSFEFALA IVEALVGKDM ANQVKAPLVL KD.

Product Science Overview

Structure and Expression

PARK7 Mouse Recombinant is produced in E. coli as a single, non-glycosylated polypeptide chain containing 212 amino acids (1-189 a.a) and has a molecular mass of 22.4 kDa . The recombinant protein is fused to a 23 amino acid His-tag at the N-terminus, which facilitates its purification through chromatographic techniques .

Function and Mechanism

DJ-1 exhibits several types of catalytic activity, including functioning as a protein deglycase (EC 3.5.1.124) . It acts as a positive regulator of androgen receptor-dependent transcription and may function as a redox-sensitive chaperone, sensing oxidative stress and protecting neurons against oxidative stress and cell death .

In different cellular compartments, DJ-1 exhibits both catalytic and non-catalytic functions. For instance, oxidative stress promotes the dissociation of cytoplasmic DJ-1 dimers into monomers, which are then translocated to the nucleus. In the nucleus, DJ-1 acts as a coactivator of various signaling pathways, preventing cell death . In mitochondria, DJ-1 is found in the synthasome, where it interacts with the β ATP synthase subunit .

Role in Parkinson’s Disease

Mutations in the DJ-1 gene (PARK7) are associated with autosomal recessive early-onset Parkinson’s disease (PD) . These mutations often result in impaired dimerization, stability, and folding of the protein, leading to its dysfunction . Downregulation of the DJ-1 gene increases the sensitivity of cells to neurotoxins, which is a characteristic feature of PD . Introduction of recombinant DJ-1 protein has been shown to attenuate the manifestation of PD pathology in experimental models .

Applications

The recombinant PARK7 protein is used in various research applications to study its role in neuroprotection and its potential therapeutic effects in PD models. It is also utilized in biochemical assays to understand its interaction with other proteins and its function under oxidative stress conditions .

Storage and Stability

PARK7 Mouse Recombinant protein is typically stored at -20°C for long-term storage and at 4°C if it will be used within 2-4 weeks . It is recommended to avoid multiple freeze-thaw cycles to maintain its stability .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.